![]() ![]() | Generic Cleocin (Clindamycin)Antibiotics Drug, Inflammatory Drug | ||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Most popular quantity. Information About Generic Cleocin (Clindamycin)What is Generic Cleocin (Clindamycin)Working of Generic Cleocin (Clindamycin)Generic Cleocin (Clindamycin) Dosage or AdministrationPrecautions for Taking Generic Cleocin (Clindamycin)Interaction of Generic Cleocin (Clindamycin) with Other DrugsSide effects of Generic Cleocin (Clindamycin)
Clindamycin is generic equivalent of Cleocin, it is used for Treatment of serious infections caused by susceptible strains of specific microorganisms; treatment of acne vulgaris (topical use); treatment of bacterial vaginosis (vaginal use). Unlabeled use(s): Treatment of CNS toxoplasmosis in AIDS patients, Organism: Pneumocystis carinii pneumonia and acute pelvic inflammatory disease; treatment of rosacea (topical). What is Generic Cleocin (Clindamycin)Generic Cleocin belong to calss Antibiotic/Lincosamide. Generic Cleocin Suppresses bacterial protein synthesis. Generic Cleocin (Clindamycin) Dosage or AdministrationADULTS: PO 150–450 mg q 6 hr. IM/IV 0.6–2.7 g/day divided into 2–4 doses. Do not use > 600 mg in single IM injection. CHILDREN: CLINDAMYCIN HYDROCHLORIDE: PO 8–20 mg/kg/day divided into 3–4 doses. CLINDAMYCIN PALMITATE HYDROCHLORIDE: PO 8–25 mg/kg/day divided into 3–4 doses. CHILDREN > 1 mo: IM/IV 20–40 mg/kg/day divided into 3–4 equal doses. NEONATES < 1 mo: IM/IV 15–20 mg/kg/day divided into 3–4 equal doses. Acute Pelvic Inflammatory Disease ADULTS: IV 900 mg q 8 hr with gentamicin. After discharge from hospital continue with doxycycline 100 mg bid for 10 days or oral clindamycin 450 mg 5 times daily for 10–14 days. Acne ADULTS: Topical Apply thin film to affected area bid. Vaginosis ADULTS: Intravaginal 1 applicatorful preferably at bedtime for 7 days. Precautions for Taking Generic Cleocin (Clindamycin)Pregnancy: Oral, parenteral: Category B. Clindamycin does cross the placenta. Topical, intravaginal: Category B. Lactation: Excreted in breast milk. Children: Monitor organ system functions in newborns and infants; parenteral form may contain benzyl alcohol, which can cause gasping syndrome in premature infants. Colitis: Drug can cause severe and possibly fatal colitis characterized by severe persistent diarrhea, severe abdominal cramps and possibly passage of blood and mucus. Mild cases may respond to drug discontinuation. More severe cases may need fluid, electrolyte and protein supplementation, corticosteroids and other antibiotics. Consider possibility of pseudomembranous colitis. Elderly or debilitated patients: May not tolerate diarrhea well (dehydration). Hypersensitivity: Use drug with caution in patients with asthma or significant allergies. Meningitis: Drug does not diffuse into CSF. Do not use to treat meningitis. Interaction of Generic Cleocin (Clindamycin) with Other DrugsErythromycin: May cause antagonism. Kaolin-pectin antidiarrheals: May delay absorption of clindamycin. Nondepolarizing neuromuscular blockers: May enhance actions of blockers. INCOMPATIBILITIES: Ampicillin, phenytoin sodium, barbiturates, aminophylline, magnesium sulfate, calcium gluconate. Side effects of Generic Cleocin (Clindamycin)CV: Hypotension, cardiopulmonary arrest. DERM: Hypersensitivity (eg, skin rash,
urticaria, erythema multiforme, some cases resembling Stevens-Johnson syndrome).
GI: Diarrhea; colitis, including pseudomembranous colitis; nausea; vomiting;
abdominal pain; esophagitis; anorexia. GU: Azotemia; oliguria; proteinuria;
cervicitis or vaginitis (with intravaginal form of drug). HEMA: Neutropenia;
leukopenia; agranulocytosis; thrombocytopenic purpura. HEPA: Jaundice; liver
function test abnormalities. OTHER: Pain after injection; induration and sterile
abscess after intramuscular injection; thrombophlebitis after intravenous infusion;
anaphylaxis. Topical or vaginal use may theoretically produce adverse effects
seen with systemic use as a result of absorption. | |||||||||||||||||||||||||||||||||||||||||